Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lepu Biopharma Co., Ltd. successfully held its 2023 Annual General Meeting (AGM) on June 19, 2024, where all proposed resolutions were passed by shareholders’ polls. Notably, the re-appointment of PricewaterhouseCoopers as the company’s auditor for 2024 and the authorization for the Board to issue additional shares were among the key resolutions approved. The AGM’s high approval rates signal robust shareholder support for the company’s direction and governance.
For further insights into HK:2157 stock, check out TipRanks’ Stock Analysis page.